NCT00960284View on ClinicalTrials.gov

Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Pancreatic Cancer
Interventions
DRUG

capecitabine

Given orally

DRUG

cisplatin

Given IV

DRUG

epirubicin hydrochloride

Given IV

DRUG

fluorouracil

Given IV

DRUG

gemcitabine hydrochloride

Given IV

Trial Locations (1)

20132

Istituto Scientifico H. San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT00960284 - Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | Biotech Hunter | Biotech Hunter